Literature DB >> 18031558

L-ficolin binding and lectin pathway activation by acetylated low-density lipoprotein.

J Faro1, Y Chen, P Jhaveri, P Oza, G T Spear, T F Lint, H Gewurz.   

Abstract

L-ficolin, like mannan-binding lectin (MBL), is a lectin pathway activator present in normal human plasma. Upon binding ligand, l-ficolin similarly initiates C4 cleavage via the serine protease MBL-associated serine protease-2 (MASP-2). We sought further insight into l-ficolin binding reactions and MASP-2 activation by passing plasma through GlcNAc-derivatized Sepharose. l-Ficolin bound in 1.0 M NaCl-ethylenediamine tetraacetic acid (EDTA), and remained bound in NaCl-free EDTA, while MASP-2 eluted in proenzyme form ( approximately 20% yield, > 40 000-fold purification). L-Ficolin was eluted with GlcNAc in 1.0 M NaCl ( approximately 10% yield, > 3000-fold purification), with trace amounts of C3, alpha(2)-macroglobulin and both native and activated MASP-2. These preparations were utilized to investigate l-ficolin reactivities with acetylated low-density lipoprotein (A-LDL) as a model ligand in albumin-free systems. L-Ficolin bound strongly to A-LDL in the absence as well as presence of calcium, including saline-EDTA, and was optimal in 1.0 M NaCl-EDTA, but binding failed to occur in EDTA in the absence of NaCl. The addition of l-ficolin to immobilized A-LDL resulted in activation of MASP-2 in unmodified but not ficolin-depleted plasma unless l-ficolin was restored. We conclude that A-LDL is a useful ligand for investigation of l-ficolin function; both binding and activation are optimally examined in systems free of albumin; and ligand binding in 1.0 M NaCl in EDTA can be useful in the isolation of l-ficolin and native MASP-2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031558      PMCID: PMC2276939          DOI: 10.1111/j.1365-2249.2007.03538.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  L-ficolin is a pattern recognition molecule specific for acetyl groups.

Authors:  Anders Krarup; Steffen Thiel; Annette Hansen; Teizo Fujita; Jens C Jensenius
Journal:  J Biol Chem       Date:  2004-08-25       Impact factor: 5.157

2.  Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci.

Authors:  Youko Aoyagi; Elisabeth E Adderson; Jin G Min; Misao Matsushita; Teizo Fujita; Shinji Takahashi; Yoshiyuki Okuwaki; John F Bohnsack
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

3.  Purification and binding properties of a human ficolin-like protein.

Authors:  Y Le; S M Tan; S H Lee; O L Kon; J Lu
Journal:  J Immunol Methods       Date:  1997-05-12       Impact factor: 2.303

4.  Two oligomeric forms of plasma ficolin have differential lectin activity.

Authors:  T Ohashi; H P Erickson
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  Structural insights into the innate immune recognition specificities of L- and H-ficolins.

Authors:  Virginie Garlatti; Nicolas Belloy; Lydie Martin; Monique Lacroix; Misao Matsushita; Yuichi Endo; Teizo Fujita; Juan Carlos Fontecilla-Camps; Gérard J Arlaud; Nicole M Thielens; Christine Gaboriaud
Journal:  EMBO J       Date:  2007-01-11       Impact factor: 11.598

Review 6.  Ficolins and the lectin complement pathway.

Authors:  M Matsushita; T Fujita
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

7.  P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients.

Authors:  D C Kilpatrick; T Fujita; M Matsushita
Journal:  Immunol Lett       Date:  1999-04-01       Impact factor: 3.685

8.  MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway.

Authors:  M R Dahl; S Thiel; M Matsushita; T Fujita; A C Willis; T Christensen; T Vorup-Jensen; J C Jensenius
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

9.  Molecular organization of human Ficolin-2.

Authors:  Tina Hummelshoj; Nicole M Thielens; Hans O Madsen; Gérard J Arlaud; Robert B Sim; Peter Garred
Journal:  Mol Immunol       Date:  2006-04-03       Impact factor: 4.407

Review 10.  The mannose-binding lectin: a prototypic pattern recognition molecule.

Authors:  Kazue Takahashi; Wk Eddie Ip; Ian C Michelow; R Alan B Ezekowitz
Journal:  Curr Opin Immunol       Date:  2005-12-20       Impact factor: 7.486

View more
  9 in total

1.  Differential complement activation pathways promote C3b deposition on native and acetylated LDL thereby inducing lipoprotein binding to the complement receptor 1.

Authors:  Boudewijn Klop; Pieter van der Pol; Robin van Bruggen; Yanan Wang; Marijke A de Vries; Selvetta van Santen; Joseph O'Flynn; Gert-Jan M van de Geijn; Tjin L Njo; Hans W Janssen; Peter de Man; J Wouter Jukema; Ton J Rabelink; Patrick C N Rensen; Cees van Kooten; Manuel Castro Cabezas
Journal:  J Biol Chem       Date:  2014-10-27       Impact factor: 5.157

2.  Rapid and efficient purification of ficolin-2 using a disposable CELLine bioreactor.

Authors:  K Aaron Geno; Brady L Spencer; Moon H Nahm
Journal:  J Immunol Methods       Date:  2015-05-30       Impact factor: 2.303

3.  A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent.

Authors:  Tim J Schuijt; Jeroen Coumou; Sukanya Narasimhan; Jianfeng Dai; Kathleen Deponte; Diana Wouters; Mieke Brouwer; Anneke Oei; Joris J T H Roelofs; Alje P van Dam; Tom van der Poll; Cornelis Van't Veer; Joppe W Hovius; Erol Fikrig
Journal:  Cell Host Microbe       Date:  2011-08-18       Impact factor: 21.023

4.  Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner.

Authors:  Kusumam Joseph; Liudmila Kulik; Beth Coughlin; Kannan Kunchithapautham; Mausumi Bandyopadhyay; Steffen Thiel; Nicole M Thielens; V Michael Holers; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

5.  Diabetic dyslipidemia and exercise alter the plasma low-density lipoproteome in Yucatan pigs.

Authors:  Matthew R Richardson; Xianyin Lai; Joseph L Dixon; Michael Sturek; Frank A Witzmann
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984

6.  Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin.

Authors:  Evelyne Gout; Virginie Garlatti; David F Smith; Monique Lacroix; Chantal Dumestre-Pérard; Thomas Lunardi; Lydie Martin; Jean-Yves Cesbron; Gérard J Arlaud; Christine Gaboriaud; Nicole M Thielens
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

7.  Enzymatically modified low-density lipoprotein is recognized by c1q and activates the classical complement pathway.

Authors:  Gérard J Arlaud; Adrienn Biro; Wai Li Ling
Journal:  J Lipids       Date:  2011-03-09

Review 8.  The lectin pathway of complement and rheumatic heart disease.

Authors:  Marcia Holsbach Beltrame; Sandra Jeremias Catarino; Isabela Goeldner; Angelica Beate Winter Boldt; Iara José de Messias-Reason
Journal:  Front Pediatr       Date:  2015-01-21       Impact factor: 3.418

9.  A New Ligand-Based Method for Purifying Active Human Plasma-Derived Ficolin-3 Complexes Supports the Phenomenon of Crosstalk between Pattern-Recognition Molecules and Immunoglobulins.

Authors:  Aleksandra Man-Kupisinska; Mateusz Michalski; Anna Maciejewska; Anna S Swierzko; Maciej Cedzynski; Czeslaw Lugowski; Jolanta Lukasiewicz
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.